These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8238371)

  • 1. GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery.
    Richter G; Feddersen O; Wagner U; Barth P; Göke R; Göke B
    Am J Physiol; 1993 Oct; 265(4 Pt 1):L374-81. PubMed ID: 8238371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.
    Golpon HA; Puechner A; Welte T; Wichert PV; Feddersen CO
    Regul Pept; 2001 Dec; 102(2-3):81-6. PubMed ID: 11730979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands.
    Uttenthal LO; Blázquez E
    FEBS Lett; 1990 Mar; 262(1):139-41. PubMed ID: 2156728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.
    Perry T; Haughey NJ; Mattson MP; Egan JM; Greig NH
    J Pharmacol Exp Ther; 2002 Sep; 302(3):881-8. PubMed ID: 12183643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism.
    Nyström T; Gonon AT; Sjöholm A; Pernow J
    Regul Pept; 2005 Feb; 125(1-3):173-7. PubMed ID: 15582729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.
    Schmidtler J; Dehne K; Allescher HD; Schusdziarra V; Classen M; Holst JJ; Polack A; Schepp W
    Am J Physiol; 1994 Sep; 267(3 Pt 1):G423-32. PubMed ID: 7943240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice.
    Lachey JL; D'Alessio DA; Rinaman L; Elmquist JK; Drucker DJ; Seeley RJ
    Endocrinology; 2005 Jan; 146(1):458-62. PubMed ID: 15459118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
    Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
    Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
    Hay CW; Sinclair EM; Bermano G; Durward E; Tadayyon M; Docherty K
    J Endocrinol; 2005 Aug; 186(2):353-65. PubMed ID: 16079261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
    Sancho V; Trigo MV; González N; Valverde I; Malaisse WJ; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2005 Aug; 35(1):27-38. PubMed ID: 16087719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats.
    López-Delgado MI; Morales M; Villanueva-Peñacarrillo ML; Malaisse WJ; Valverde I
    Endocrinology; 1998 Jun; 139(6):2811-7. PubMed ID: 9607788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
    Isbil-Buyukcoskun N; Gulec G
    Regul Pept; 2004 Apr; 118(1-2):33-8. PubMed ID: 14759554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.
    Beak SA; Heath MM; Small CJ; Morgan DG; Ghatei MA; Taylor AD; Buckingham JC; Bloom SR; Smith DM
    J Clin Invest; 1998 Mar; 101(6):1334-41. PubMed ID: 9502775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minireview: the glucagon-like peptides.
    Drucker DJ
    Endocrinology; 2001 Feb; 142(2):521-7. PubMed ID: 11159819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local, exendin-(9-39)-insensitive, site of action of GLP-1 in canine ileum.
    Daniel EE; Anvari M; Fox-Threlkeld JE; McDonald TJ
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G595-602. PubMed ID: 12181172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
    Jehle PM; Jehle D; Fussgänger RD; Adler G
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.